Lundbeck
HLUN-B.CO
#2428
Rank
$6.06 B
Marketcap
$6.36
Share price
-0.13%
Change (1 day)
29.99%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total assets

Total assets on the balance sheet as of June 2024 : $5.62 Billion USD

According to Lundbeck 's latest financial reports the company's total assets are $5.62 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lundbeck - Total assets on balance sheet (from 2009 to 2024)

Total assets by year

Year Total assets Change
2023-12-31$5.54 B2.72%
2022-12-31$5.39 B2.23%
2021-12-31$5.27 B-11.41%
2020-12-31$5.95 B4.16%
2019-12-31$5.71 B62.17%
2018-12-31$3.52 B10.7%
2017-12-31$3.18 B11.3%
2016-12-31$2.86 B-8.43%
2015-12-31$3.12 B-25.37%
2014-12-31$4.18 B-4.37%
2013-12-31$4.37 B14.51%
2012-12-31$3.82 B6.88%
2011-12-31$3.57 B11.33%
2010-12-31$3.21 B-2.61%
2009-12-31$3.29 B40.27%
2008-12-31$2.35 B-2.49%
2007-12-31$2.41 B16.97%
2006-12-31$2.06 B12.01%
2005-12-31$1.84 B-12.12%
2004-12-31$2.09 B